Comparison of disease-free survival and overall survival between LACC and this study
| DFS | Follow-up | 3 years DFS No. at risk (%) | 4.5 years DFS No. at risk (%) | 5 years DFS No. at risk (%) | 10 years DFS No. at risk (%) |
| LSC/robot arm in LACC trial | 2.5 years | 87.1% 142 (45%) | 86% 80 (25%) | n/a 5 (2%) | n/a |
| Laparotomy arm in LACC trial | 2.5 years | 97.1% 134 (43%) | 96.5% 90 (29%) | n/a 7 (2%) | n/a |
| Own results | >8 years (99 months) | 96.8% 305 (78%) | 95.8% 271 (70%) | 95.7% 264 (68%) | 93.1% 138 (35%) |
| OS | Follow-up |
3 years OS
No. at risk (%) |
4.5 years OS
No. at risk (%) |
5 years OS
No. at risk (%) |
10 years OS
No. at risk (%) |
| LSC/robot arm in LACC rial | 2.5 years | 93.8% 150 (47%) | n/a 87 (27%) | n/a 5 (2%) | n/a |
| Laparotomy arm in LACC trial | 2.5 years | 99% 136 (44%) | n/a 90 (29%) | n/a 7 (2%) | n/a |
| Own results | >8 years (99 months) | 98.5% 306 (78%) | 97.8% 273 (70%) | 97.6% 265 (68%) | 95.8% 138 (35%) |
DFS, disease-free survival; LACC, Laparoscopic Approach to Cervical Cancer; OS, overall survival.